Role of JAK-inhibitors in management of Long COVID-19 syndrome: A Case-Control Study.

被引:0
|
作者
Lalwani, Lokesh Kumar
Singh, Pawan Kumar
Sharma, Vinod
Chaudhry, Dhruva
机构
关键词
D O I
10.1183/13993003.congress-2023.PA2309
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] TELEMEDICINE AT THE TIME OF COVID-19: THE EXPERIENCE WITH RA PATIENTS TREATED WITH JAK-INHIBITORS
    Garufi, C.
    Spinelli, F. R.
    Mancuso, S.
    Ceccarelli, F.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1384 - 1384
  • [2] Long COVID syndrome: a case-control study
    Xuereb, R. A.
    Gatt, A.
    Vella, K.
    Xuereb, R. G.
    Barbara, C. J.
    Fava, S.
    Magri, C. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2836 - 2836
  • [3] The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case-control study
    Torki, Ensiye
    Hoseininasab, Fahimeh
    Moradi, Marjan
    Sami, Ramin
    Sullman, Mark J. M.
    Fouladseresht, Hamed
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [4] Long COVID Syndrome: A Case-Control Study
    Xuereb, Rachel-Anne
    Borg, Marica
    Vella, Kevin
    Gatt, Alex
    Xuereb, Robert G.
    Barbara, Christopher
    Fava, Stephen
    Magri, Caroline J.
    AMERICAN JOURNAL OF MEDICINE, 2025, 138 (01): : 131 - 139
  • [5] Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study
    Singh, Pawan Kumar
    Sharma, Vinod Kumar
    Lalwani, Lokesh Kumar
    Chaudhry, Dhruva
    Govindagoudar, Manjunath B.
    Sriram, Chaudhari Pramod
    Ahuja, Aman
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2023, 23 (03): : 149 - 155
  • [6] JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
    Chen, Chong-xiang
    Wang, Jiao-jiao
    Li, Huan
    Yuan, Le-tao
    Gale, Robert Peter
    Liang, Yang
    LEUKEMIA, 2021, 35 (09) : 2616 - 2620
  • [7] JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
    Chong-xiang Chen
    Jiao-jiao Wang
    Huan Li
    Le-tao Yuan
    Robert Peter Gale
    Yang Liang
    Leukemia, 2021, 35 : 2616 - 2620
  • [8] PERSISTENT SYMPTOMS FOLLOWING RECOVERY FROM COVID-19: A PROSPECTIVE CASE-CONTROL STUDY.
    Duvuru, R.
    AlAwadhi, A.
    Halabi, M.
    HajiJama, S.
    Elsheikh, A.
    AlZaabi, S.
    Suresh, S.
    Akram, S.
    Iqbal, A.
    Safi, A. M.
    Narayanan, N. N.
    Aleabova, S.
    Elsheikh, A. M.
    Balila, M.
    Malik, Z.
    Khamis, A. H.
    Ho, S. B.
    Patkar, S.
    MEDICINE, 2023, 102 (42) : 15 - 15
  • [9] Covid-19 and Rehabilitation Outcomes: A Case-Control Study
    Petzold, Stefanie
    Carney, Roisin
    Kool, JanPieter
    Bachmann, Stefan
    PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN, 2023, 33 (01) : 17 - 27
  • [10] Mucormycosis in COVID-19 Patients: A Case-Control Study
    Pandit, Awadh Kishor
    Tangri, Poorvi
    Misra, Shubham
    Srivastava, Madakasira Vasantha Padma
    Bhatnagar, Sushma
    Thakar, Alok
    Sikka, Kapil
    Panda, Smriti
    Vishnu, Venugopalan Y.
    Singh, Rajesh Kumar
    Das, Animesh
    Radhakrishnan, Divya M.
    Srivastava, Achal Kumar
    Subramaniam, Rajeshwari
    Trikha, Anjan
    Agarwal, Ayush
    Rajan, Roopa
    Upadhyay, Vibhor
    Parikipandla, Sathish
    Singh, Anup
    Kairo, Arvind
    MICROORGANISMS, 2022, 10 (06)